ConductScience.org, home

Paper28906290

Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.

Cross RK. Inflamm Bowel Dis, 2017. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis. Papers, record 28906290. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28906290

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.
PubMed
Journal
Inflamm Bowel Dis
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
1.2
iCite
Revised in PubMed
2018-09-13
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cross RKRaymond K

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenal Cortex HormonesMajor topic
Antibodies, MonoclonalMajor topic
BeclomethasoneMajor topic
BudesonideMajor topic
Colitis, UlcerativeMajor topic
Humans
Randomized Controlled Trials as Topic
Severity of Illness Index

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42871137Stratified by baseline corticosteroid use: which advanced therapy works best for whom in ulcerative colitis?Front Med (Lausanne)2026https://conductscience.org/library/papers/42871137PubMed
42682644Salmonella Typhimurium infection complicating very early-onset inflammatory bowel disease presenting with Pseudo-intussusception: a case report.Front Pediatr2026https://conductscience.org/library/papers/42682644PubMed
42473331Engineered probiotics platform for resolvin E1 biosynthesis confers protection against inflammatory disease.Clin Transl Med2026https://conductscience.org/library/papers/42473331PubMed
42272621Progress in the Treatment of Ulcerative Colitis by Targeting NLRP3 Inflammasome.Drug Des Devel Ther2026https://conductscience.org/library/papers/42272621PubMed
40433382"Remodeling the intestinal immune microenvironment": immune regulation and tissue regeneration by mesenchymal stem/stromal cells in the repair microenvironment of inflammatory bowel disease.Front Immunol2025https://conductscience.org/library/papers/40433382PubMed
40222016Safety Outcomes in Patients With Ulcerative Colitis Using a Healthcare Administrative Database in the United States.Inflamm Bowel Dis2025https://conductscience.org/library/papers/40222016PubMed
40168091Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis.J Crohns Colitis2025https://conductscience.org/library/papers/40168091PubMed
39671695Etrasimod as a Monotherapy or With Concomitant Use of Corticosteroids and/or Aminosalicylates: Results From the ELEVATE UC Clinical Program.Inflamm Bowel Dis2025https://conductscience.org/library/papers/39671695PubMed
39306680
Etrasimod Corticosteroid-Free Efficacy, Impact of Concomitant Corticosteroids on Efficacy and Safety, and Corticosteroid-Sparing Effect in Ulcerative Colitis: Analyses of the ELEVATE UC Clinical Program.
J Crohns Colitis2025https://conductscience.org/library/papers/39306680PubMed
39086989Switching within versus out of class following first-line TNFi failure in ulcerative colitis: real-world outcomes from a German claims data analysis.Ther Adv Gastroenterol2024https://conductscience.org/library/papers/39086989PubMed
38308626Burden of chronic corticosteroid use among patients with ulcerative colitis initiated on targeted treatment or conventional therapy in the United States.J Manag Care Spec Pharm2024https://conductscience.org/library/papers/38308626PubMed
37533463Thiol-Disulfide Exchange Coordinates the Release of Nitric Oxide and Dexamethasone for Synergistic Regulation of Intestinal Microenvironment in Colitis.Research (Wash D C)2023https://conductscience.org/library/papers/37533463PubMed
36225410Glucocorticoids-Induced Neuropsychiatric Disorders in Patients With Inflammatory Bowel Disease: A Systematic Review.Cureus2022https://conductscience.org/library/papers/36225410PubMed
34386591Clinical characteristics of ulcerative colitis in elderly patients.JGH Open2021https://conductscience.org/library/papers/34386591PubMed
34165201The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme.Aliment Pharmacol Ther2021https://conductscience.org/library/papers/34165201PubMed
33324993
Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan® Administrative Claims Database With Tofacitinib Trial Data.
Inflamm Bowel Dis2021https://conductscience.org/library/papers/33324993PubMed
32606883
Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1.
Clin Exp Gastroenterol2020https://conductscience.org/library/papers/32606883PubMed
32370215Walnut Oil Alleviates Intestinal Inflammation and Restores Intestinal Barrier Function in Mice.Nutrients2020https://conductscience.org/library/papers/32370215PubMed
30686824Intestinal glucocorticoid synthesis enzymes in pediatric inflammatory bowel disease patients.Genes Immun2019https://conductscience.org/library/papers/30686824PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28906290

GET https://conductscience.org/api/papers/v1/28906290/authors